Moreover, sequencing data from Chubb et al. identified only one carrier of a heterozygous disruptive BUB1B variant (and no predicted pathogenic missense variants) among 1006 familial/early onset CRC patients and none among controls [28], further supporting the rarity of these alterations. This evidence concerns the gene BUB1B and colorectal carcinoma.